Evidence map›Paper›PMID 41364527›Full record

ArticleJCI insight2026

Rare epigenetic alterations are conserved across hematopoietic differentiation stages after mycobacterial infection.

Brandon T Tran, Pamela N Luna, Ruoqiong Cao, Duy T Le, Apoorva Thatavarty, Laure Maneix, Bailee N Kain, Scott Koh, Andre Catic, Katherine Y King

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brandon T TranGraduate Program in Cancer and Cell Biology.
Pamela N LunaDepartment of Molecular and Human Genetics.
Ruoqiong CaoDepartment of Pediatrics, Division of Infectious Disease, Texas Children's Hospital and Baylor College of Medicine.
Duy T LeDepartment of Pediatrics, Division of Infectious Disease, Texas Children's Hospital and Baylor College of Medicine.
Apoorva ThatavartyDepartment of Pediatrics, Division of Infectious Disease, Texas Children's Hospital and Baylor College of Medicine.
Laure ManeixStem Cells and Regenerative Medicine Center.
Bailee N KainDivision of Experimental Hematology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Scott KohDepartment of Pediatrics, Division of Infectious Disease, Texas Children's Hospital and Baylor College of Medicine.
Andre CaticStem Cells and Regenerative Medicine Center.
Katherine Y KingDepartment of Pediatrics, Division of Infectious Disease, Texas Children's Hospital and Baylor College of Medicine.

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Suzanne AW Fuqua · 2007 to 2026
$73.9M
Project 3: Contribution of inflammation and DNA damaging factors to clonal expansion and malignant transformation in a community cohort of older adultsP01CA265748 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MARGARET A. GOODELL · 2022 to 2026
$13.6M
Impact of Infection and Inflammation on Primitive HematopoiesisR35HL155672 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Katherine Yudeh King · 2021 to 2026
$5.1M
Microbiota-dependent regulation of primitive hematopoiesesR01AI141716 · NIAID · WASHINGTON UNIVERSITY · PI BALDRIDGE, MEGAN T · 2019 to 2023
$2.3M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
Epigenetic modification of hematopoietic stem and progenitor cells in inflammation-induced differentiationF31HL164287 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI TRAN, BRANDON T · 2022 to 2024
$143k
Cellular Interactions and Competition in Clonal HematopoiesisF30HL172468 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Apoorva Thatavarty · 2024 to 2026
$105k
NCI NIH HHS P01 CA265748NCI NIH HHS P30 CA125123NCRR NIH HHS S10 RR024574NHLBI NIH HHS F30 HL172468NHLBI NIH HHS F31 HL164287NHLBI NIH HHS R35 HL155672NIAID NIH HHS R01 AI141716
6 · The paper itself

Abstract

Infection leads to durable cell-autonomous changes in hematopoietic stem and progenitor cells (HSPCs), resulting in production of innate immune cells with heightened immunity. The mechanisms underlying this phenomenon, termed central trained immunity, remain poorly understood. We hypothesized that infection induces histone modifications leading to changes in chromatin accessibility that are conserved during differentiation from HSPCs to myeloid progenitors and monocytes. We conducted genome-wide surveillance of histone marks H3K27ac and H3K4me3 and chromatin accessibility in hematopoietic stem cells, multipotent progenitor 3, granulocyte-monocyte progenitors, and monocytes and macrophages of naive and Mycobacterium avium-infected mice. IFN signaling pathways and related transcription factor binding motifs including IRFs, NF-κB, and CEBP showed increased activating histone marks and chromatin accessibility across cell types. However, histone marks and increased chromatin accessibility were conserved at only a few loci, notably Irf1 and Gbp6. Knock out of IRF1 disrupted enhanced mitochondrial respiration and bacterial killing in human monocyte cell lines, while GBP6-KO monocyte cell lines showed dysregulated mitochondrial respiration. In summary, this study identifies IRF1 and GBP6 as 2 key loci at which infection-induced systemic inflammation leads to epigenetic changes that are conserved from HSPCs to downstream monocytes, providing a mechanistic avenue for central trained immunity.

Indexed as

Cell DifferentiationEpigenesis, GeneticHematopoietic Stem CellsMycobacterium InfectionsAnimalsChromatinHistonesHumansImmunity, InnateInterferon Regulatory Factor-1MacrophagesMiceMice, Inbred C57BLMice, KnockoutMonocytesMycobacterium aviumChromatinHistonesInterferon Regulatory Factor-1EpigeneticsHematologyImmunologyInnate immunityMemory

Identifiers

PMID41364527
PMCPMC12892905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.